Opioid and Neuropathic Use After Initiating btsDMARDs in RA
Dr. Julian Segan discusses Abstract 0925 at the ACR22 Convergence meeting.
Search for Terms or Answers
Dr. Julian Segan discusses Abstract 0925 at the ACR22 Convergence meeting.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.